Alzheimer's Disease Long-term Follow-up Study (ALF Study)
NCT00165724 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 114
Last updated 2021-12-30
Summary
Open study for efficacy and safety of donepezil treatment during 48 weeks
Conditions
Interventions
- DRUG
-
Donepezil Hydrochloride
Sponsors & Collaborators
-
Eisai Korea Inc.
lead INDUSTRY
Principal Investigators
-
Jiheed Mun · Eisai Korea Inc.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2006-07-31
- Completion
- 2006-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
NCT01251718 ·Status: COMPLETED
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
NCT02162264 ·Status: COMPLETED
-
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
NCT02178124 ·Status: COMPLETED ·Phase: PHASE1
-
Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
NCT02448784 ·Status: COMPLETED
-
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
NCT02695004 ·Status: COMPLETED ·Phase: PHASE1
-
Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
NCT00165750 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
NCT03441516 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
NCT00571064 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
NCT03363269 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
NCT00188812 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
NCT02248116 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
NCT00934375 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
NCT01860625 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
NCT04111211 ·Status: COMPLETED
-
An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
NCT01245530 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
NCT00381381 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
NCT02648906 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
NCT00096473 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
NCT05811000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
NCT03112096 ·Status: COMPLETED ·Phase: PHASE1
-
Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
NCT00165737 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
NCT01023867 ·Status: COMPLETED ·Phase: NA
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias
NCT04250376 ·Status: UNKNOWN ·Phase: NA